We are live on ! Find out more

18 hedge funds and large institutions have $287K invested in Imunon in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

20% more funds holding

Funds holding: 1518 (+3)

0.01% more ownership

Funds ownership: 0.34%0.34% (+0.01%)

29% less capital invested

Capital invested by funds: $403K → $287K (-$116K)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q4 2023 in Review

18 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2023, worth a combined $287K — down 29% from $403K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IMNN positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $26.7K. The largest seller was Vanguard Group, cutting an estimated $66.2K.

  • 18 institutional investors held Imunon (IMNN) as of Q4 2023, up from 15 in Q3 2023.
  • Funds reported $287K of Imunon stock for Q4 2023, down 29% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q4 2023 and 1 closed out, a net change of +3 holders.
  • The largest Imunon buyer in Q4 2023 was HRT Financial, an estimated $26.7K added.
  • The largest Imunon seller in Q4 2023 was Vanguard Group, an estimated $66.2K sold.

Based on aggregated 13F filings for Q4 2023.